Cardia Bioplastics Wins $500K Hygiene Products Contract for American Market
Cardia Bioplastics is pleased to announce that it has been awarded an annual supply contract for hygiene films made using Cardia Biohybrid™ technology worth at least US$500,000 p.a. Cardia signed the supply deal with a leading American diaper products company.
Using the hygiene films made from Cardia BiohybridTM technology, the American diaper products company (can not be named due to commercial sensitivity) now offers an environmentally sensitive diaper that uses less petroleum-based and more sustainable materials. In order to complete the product offering, the diapers are packed in an outer packaging also made using Cardia BiohybridTM technology.
The combination of film packaging with performance, environmental profile, soft touch, matt finish, excellent printability and cost effectiveness makes Cardia BiohybridTM technology a most interesting product offering to the global hygiene and personal care products industry.
Cardia Bioplastics will supply the Cardia BiohybridTM hygiene films from its Nanjing/China based film manufacturing plant.
About Cardia Bioplastics
Cardia Bioplastics Limited (ASX CODE: CNN) develops, manufactures and markets its patented renewable resource based materials and finished products derived from Cardia's proprietary technology for the global packaging and plastic products industries. The company holds a strong patent portfolio and its growth is fuelled by the global trend towards sustainable packaging. Established in Australia in 2002 as Biograde, the company Headquarters and Global Applications Development Centre is in Melbourne, Australia. The Product Development Centre and manufacturing plant for resins and finished goods is in Nanjing, China and soon to manufacture under a joint venture for finished goods in Malaysia. There are Cardia Bioplastics offices in the Americas, Australia, Europe and Asia, and a network of leading distributors across the Americas, Asia and Europe. Visit www.cardiabioplastics.com.